CONTRATOS ART. 60
Kontratua
A PHASE IV OPEN-LABEL CLINICAL TRIAL TO EVALUATE THE EFFICACY OF IKERVIS ON CLINICAL PARAMETERS AND MOLECULAR/CELLULAR BIOMARKERS IN DRY PATIENTS WITH SEVERE DERATITIS WHO HAVE NOT IMPROVED DESPITE REGULAR USE OF TEAR SUBSTITUTES BEFORE AND AFTER EXPOSURE TO AN ADVERSE CONTROLLED ENVIRONMENT.
Finantzatzailea:
SANTEN SA
date_range
Iraupena 2019(e)ko apirila-(a)k 29-(e)tik 2021(e)ko apirila-(a)k 28-(e)ra izan da
(24 months)
euro
60.677,20 EUR
Europar-arlokoak.